Arrowhead Pharmaceuticals...

AI Score

0

Unlock

18.04
-0.87 (-4.60%)
At close: Jan 14, 2025, 3:59 PM
18.38
1.88%
After-hours Jan 14, 2025, 04:09 PM EST

Arrowhead Pharmaceuticals Statistics

Share Statistics

Arrowhead Pharmaceuticals has 124.43M shares outstanding. The number of shares has increased by 0.43% in one year.

Shares Outstanding 124.43M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.1%
Owned by Institutions (%) n/a
Shares Floating 115.84M
Failed to Deliver (FTD) Shares 780
FTD / Avg. Volume 0.05%

Short Selling Information

The latest short interest is 9.45M, so 7.59% of the outstanding shares have been sold short.

Short Interest 9.45M
Short % of Shares Out 7.59%
Short % of Float 8.14%
Short Ratio (days to cover) 8.94

Valuation Ratios

The PE ratio is -3.87 and the forward PE ratio is -5.1.

PE Ratio -3.87
Forward PE -5.1
PS Ratio 653.4
Forward PS 9.5
PB Ratio 12.51
P/FCF Ratio -3.84
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Arrowhead Pharmaceuticals Inc. has an Enterprise Value (EV) of 2.87B.

EV / Earnings -4.79
EV / Sales 808.97
EV / EBITDA -5.12
EV / EBIT -4.78
EV / FCF -4.75

Financial Position

The company has a current ratio of 6.74, with a Debt / Equity ratio of 2.15.

Current Ratio 6.74
Quick Ratio 6.74
Debt / Equity 2.15
Total Debt / Capitalization 68.3
Cash Flow / Debt -1.16
Interest Coverage -18.58

Financial Efficiency

Return on equity (ROE) is -3.23% and return on capital (ROIC) is -85.28%.

Return on Equity (ROE) -3.23%
Return on Assets (ROA) -0.53%
Return on Capital (ROIC) -85.28%
Revenue Per Employee 6.76K
Profits Per Employee -1.14M
Employee Count 525
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax -2.77M
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -48.59% in the last 52 weeks. The beta is 0.93, so Arrowhead Pharmaceuticals 's price volatility has been higher than the market average.

Beta 0.93
52-Week Price Change -48.59%
50-Day Moving Average 20.85
200-Day Moving Average 23.05
Relative Strength Index (RSI) 36.68
Average Volume (20 Days) 1.52M

Income Statement

In the last 12 months, Arrowhead Pharmaceuticals had revenue of 3.55M and earned -599.49M in profits. Earnings per share was -5.

Revenue 3.55M
Gross Profit 3.55M
Operating Income -601.08M
Net Income -599.49M
EBITDA -561.51M
EBIT -601.08M
Earnings Per Share (EPS) -5
Full Income Statement

Balance Sheet

The company has 102.69M in cash and 510.55M in debt, giving a net cash position of -407.87M.

Cash & Cash Equivalents 102.69M
Total Debt 510.55M
Net Cash -407.87M
Retained Earnings -1.63B
Total Assets 1.14B
Working Capital 592.30M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -462.85M and capital expenditures -141.47M, giving a free cash flow of -604.32M.

Operating Cash Flow -462.85M
Capital Expenditures -141.47M
Free Cash Flow -604.32M
FCF Per Share -5.05
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -16.93K% and -16.88K%.

Gross Margin 100%
Operating Margin -16.93K%
Pretax Margin -17.25K%
Profit Margin -16.88K%
EBITDA Margin -15.81K%
EBIT Margin -16.93K%
FCF Margin -17.02K%

Dividends & Yields

ARWR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -27.72%
FCF Yield -26.92%
Dividend Details

Analyst Forecast

The average price target for ARWR is $42, which is 132.8% higher than the current price. The consensus rating is "Buy".

Price Target $42
Price Target Difference 132.8%
Analyst Consensus Buy
Analyst Count 10
Stock Forecasts

Stock Splits

The last stock split was on Nov 17, 2011. It was a backward split with a ratio of 1:10.

Last Split Date Nov 17, 2011
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score -1.51
Piotroski F-Score 3